Form 8-K - Current report:
SEC Accession No. 0001185185-23-000448
Filing Date
2023-05-08
Accepted
2023-05-05 18:19:37
Documents
15
Period of Report
2023-05-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igcpharma20230505_8k.htm   iXBRL 8-K 33947
2 EXHIBIT 10.1 ex_514800.htm EX-10.1 87780
7 igc-logo1.jpg GRAPHIC 11390
  Complete submission text file 0001185185-23-000448.txt   301372

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA igc-20230505.xsd EX-101.SCH 3182
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20230505_def.xml EX-101.DEF 11004
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20230505_lab.xml EX-101.LAB 21038
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20230505_pre.xml EX-101.PRE 11405
9 EXTRACTED XBRL INSTANCE DOCUMENT igcpharma20230505_8k_htm.xml XML 2599
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 23895366
SIC: 2834 Pharmaceutical Preparations